刊名 |
Medicinal Plant |
作者 |
Huang YANG, Xingjun CHEN, Yan LIN |
作者单位 |
State Key Laboratory of Discovery and Utilization of Functional Components in Traditional Chinese Medicine, Guizhou Medical University; Engineering Research Center of Authentic Medicinal Materials for Chronic Disease Prevention and Treatment under Guizhou Provincial Department of Education |
DOI |
10.19601/j.cnki.issn2152-3924.2025.03.009 |
年份 |
2025 |
刊期 |
3 |
页码 |
32-35 |
关键词 |
Sophora flavescens, Kurarinol A (KA), TGF/Smad signaling pathway, Anti-hepatic fibrosis |
摘要 |
[Objectives] To investigate the anti-hepatic fibrosis mechanism of lavandulyl flavonoid Kurarinol A (KA) from Sophora flavescens through the TGF/Smad signaling pathway. [Methods] A hepatic fibrosis model was established by TGF-β1-induced activation of human hepatic stellate cells LX-2. Western blot and RT-qPCR techniques were employed to study the anti-fibrotic mechanism of KA through the TGF/Smad signaling pathway. [Results] KA exerted anti-hepatic fibrosis effects by significantly reducing the gene expression levels of TGF-β1, Smad2, Smad3, and Smad4, as well as markedly decreasing the protein expression levels of TGF-β1, p-Smad2/3/Smad2/3, and Smad4. [Conclusions] KA demonstrates significant anti-hepatic fibrosis activity and alleviates liver fibrosis through the TGF/Smad signaling pathway. |